These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 30765635)
1. [Induction and Palliative Chemotherapy for Head and Neck Cancer]. Honma Y Gan To Kagaku Ryoho; 2019 Jan; 46(1):14-20. PubMed ID: 30765635 [TBL] [Abstract][Full Text] [Related]
2. The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer. Misiukiewicz K; Gupta V; Posner M Ann Oncol; 2017 Sep; 28(9):2051-2054. PubMed ID: 28911089 [No Abstract] [Full Text] [Related]
3. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future? Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883 [TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study. Perri F; Muto P; Argenone A; Ionna F; Longo F; Fulciniti F; Sandomenico F; Daponte A; Caponigro F Oncology; 2013; 84(4):251-4. PubMed ID: 23428719 [TBL] [Abstract][Full Text] [Related]
5. Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx. Loong HH; Winquist E; Waldron J; Chen EX; Kim J; Palma D; Read N; Razak AR; Diaz-Padilla I; Chan K; Bayley A; Hossain M; Wang L; Chin S; Siu LL; Hope A Eur J Cancer; 2014 Sep; 50(13):2263-70. PubMed ID: 24953566 [TBL] [Abstract][Full Text] [Related]
6. Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium. Hainsworth JD; Spigel DR; Greco FA; Shipley DL; Peyton J; Rubin M; Stipanov M; Meluch A Cancer J; 2011; 17(5):267-72. PubMed ID: 21952273 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma. Yang WC; Chen CH; Tang JY; Wu CF; Liu YC; Sun Y; Lin SF Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400 [TBL] [Abstract][Full Text] [Related]
8. A new look at induction chemotherapy in locally advanced head and neck cancer. Vermorken JB Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881 [No Abstract] [Full Text] [Related]
9. Induction chemotherapy for squamous cancer of the head and neck. Kies MS Curr Oncol Rep; 2007 Mar; 9(2):129-33. PubMed ID: 17288879 [TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy for head and neck cancer: current status and perspectives. Kawashima M Int J Clin Oncol; 2004 Dec; 9(6):421-34. PubMed ID: 15616872 [TBL] [Abstract][Full Text] [Related]
11. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status. Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650 [TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy for head and neck cancer: recent data. Vokes EE Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882 [TBL] [Abstract][Full Text] [Related]
13. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010? Porceddu SV Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417 [No Abstract] [Full Text] [Related]
14. Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck. Ready NE; Rathore R; Johnson TT; Nadeem A; Chougule P; Ruhl C; Radie-Keane K; Theall K; Wanebo HJ; Marcello J; Kennedy T Am J Clin Oncol; 2012 Feb; 35(1):6-12. PubMed ID: 21293244 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of head and neck cancer]. Kohno N; Nakazawa E; Kusunoki M; Nishiya M Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819 [TBL] [Abstract][Full Text] [Related]
16. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Bernier J Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730 [TBL] [Abstract][Full Text] [Related]
18. Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer-Systematic Review and Meta-analysis. Vidal L; Ben Aharon I; Limon D; Cohen E; Popovtzer A Cancer J; 2017; 23(2):79-83. PubMed ID: 28410291 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy in locally advanced head and neck squamous cell carcinoma. Gyawali B; Shimokata T; Honda K; Ando Y Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194 [TBL] [Abstract][Full Text] [Related]
20. [Chemoradiotherapy for patients with advanced head and neck cancer]. Tsukuda M Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]